Total Payments
$237.46
2024 Payments
$29.14
Companies
8
Transactions
21
Medicare Patients
94,045
Medicare Billing
$3.8M
Payment Breakdown by Category
Food & Beverage$237.46 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $237.46 | 12 | 100.0% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$237.46
12 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myriad Genetic Laboratories, Inc. | $78.22 | 4 | $0 (2022) |
| Beckman Coulter, Inc. | $46.69 | 3 | $0 (2021) |
| Foundation Medicine, Inc. | $30.51 | 1 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $30.12 | 2 | $0 (2017) |
| Tempus AI, Inc | $29.14 | 1 | $0 (2024) |
| Medwest Associates | $22.78 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.14 | 3 | Tempus AI, Inc ($29.14) |
| 2023 | $0 | 1 | SN Holdings, LLC |
| 2022 | $45.78 | 3 | Foundation Medicine, Inc. ($30.51) |
| 2021 | $94.74 | 6 | Myriad Genetic Laboratories, Inc. ($62.95) |
| 2020 | $0 | 1 | UroGPO LLC |
| 2019 | $22.78 | 2 | Medwest Associates ($22.78) |
| 2018 | $14.90 | 2 | Beckman Coulter, Inc. ($14.90) |
| 2017 | $30.12 | 3 | Dendreon Pharmaceuticals LLC ($30.12) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $29.14 | General |
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2023 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 04/26/2022 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 2022 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 11/03/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $21.56 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 09/22/2021 | Beckman Coulter, Inc. | UNICEL DXI ACCESS (Device) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Devices | ||||||
| 08/04/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $20.22 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 04/22/2021 | Beckman Coulter, Inc. | DXI 600 (Device) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Devices | ||||||
| 04/20/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $21.17 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 2021 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2020 | UroGPO LLC | — | — | — | $0.00 | Ownership |
| 03/23/2019 | Medwest Associates | — | Food and Beverage | In-kind items and services | $22.78 | General |
| 2019 | UroGPO LLC | — | — | — | $0.00 | Ownership |
| 09/25/2018 | Beckman Coulter, Inc. | UNICEL DXH (Device) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: HEMATOLOGY | ||||||
| 2018 | UroGPO LLC | — | — | — | $0.00 | Ownership |
| 10/16/2017 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/16/2017 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 2017 | UroGPO LLC | — | — | — | $0.00 | Ownership |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 50 | 31,616 | 50,214 | $5.2M | $1.4M |
| 2021 | 51 | 31,832 | 50,468 | $5.2M | $1.4M |
| 2020 | 51 | 30,597 | 44,832 | $4.3M | $1.1M |
Total Patients
94,045
Total Services
145,514
Medicare Billing
$3.8M
Procedure Codes
152
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87900 | Infectious agent drug susceptibility analysis | Office | 2022 | 1,551 | 1,690 | $660,790 | $215,901 | 32.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 7,922 | 11,251 | $1.0M | $203,762 | 20.1% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2022 | 586 | 592 | $710,400 | $174,992 | 24.6% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 359 | 4,642 | $487,410 | $159,948 | 32.8% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2022 | 1,457 | 1,601 | $336,210 | $84,952 | 25.3% |
| 87086 | Bacterial colony count, urine | Office | 2022 | 5,771 | 9,262 | $277,860 | $73,571 | 26.5% |
| 88121 | Cell examination of urine, computer-assisted | Office | 2022 | 134 | 152 | $273,600 | $54,506 | 19.9% |
| 87799 | Detection test by nucleic acid for organism, quantification | Office | 2022 | 359 | 1,266 | $163,314 | $53,252 | 32.6% |
| 84403 | Testosterone (hormone) level, total | Office | 2022 | 1,009 | 1,737 | $191,070 | $43,987 | 23.0% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Office | 2022 | 151 | 234 | $86,580 | $33,281 | 38.4% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2022 | 2,366 | 3,833 | $114,990 | $32,617 | 28.4% |
| 87482 | Detection test for candida species (yeast), quantification | Office | 2022 | 359 | 422 | $70,474 | $23,098 | 32.8% |
| 87088 | Bacterial urine culture | Office | 2022 | 1,943 | 2,892 | $86,760 | $22,996 | 26.5% |
| 87652 | Detection test by nucleic acid for strep (streptococcus, group a), quantification | Office | 2022 | 359 | 422 | $52,750 | $17,303 | 32.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 167 | 291 | $90,210 | $15,728 | 17.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 1,046 | 1,998 | $69,930 | $15,265 | 21.8% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2022 | 359 | 422 | $44,310 | $14,541 | 32.8% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2022 | 359 | 422 | $44,310 | $14,541 | 32.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 799 | 1,368 | $61,560 | $14,176 | 23.0% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2022 | 1,020 | 1,480 | $44,400 | $11,778 | 26.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 1,046 | 1,342 | $53,680 | $11,172 | 20.8% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2022 | 508 | 508 | $45,720 | $9,671 | 21.2% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2022 | 440 | 509 | $45,810 | $9,207 | 20.1% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Office | 2022 | 35 | 37 | $19,347 | $9,042 | 46.7% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2022 | 165 | 222 | $19,980 | $4,731 | 23.7% |
About Dr. Lester Raff, M.D
Dr. Lester Raff, M.D is a Specialist healthcare provider based in Westchester, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710943220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lester Raff, M.D has received a total of $237.46 in payments from pharmaceutical and medical device companies, with $29.14 received in 2024. These payments were reported across 21 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($237.46).
As a Medicare-enrolled provider, Raff has provided services to 94,045 Medicare beneficiaries, totaling 145,514 services with total Medicare billing of $3.8M. Data is available for 3 years (2020–2022), covering 152 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Clinical Pathology/Laboratory Medicine, Anatomic Pathology & Clinical Pathology
- Location Westchester, IL
- Active Since 04/24/2006
- Last Updated 08/21/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1710943220
Products in Payments
- Prolaris (Device) $78.22
- FOUNDATIONONE (Device) $30.51
- PROVENGE (Drug) $30.12
- DXI 600 (Device) $18.36
- UNICEL DXH (Device) $14.90
- UNICEL DXI ACCESS (Device) $13.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.